Latest news

  • 13 July 2018

    Bilan semestriel du contrat de liquidité Sensorion avec la société de bourse Kepler Cheuvreux. Read (in french only)

  • 04 July 2018

    Information relative au nombre total de droits de vote et d’actions composant le capital social. Lire

  • Company

    Sensorion combines world-class, scientific excellence and top-tier execution capabilities to deliver first-in-class therapeutics as a “pure player” focused on debilitating inner ear disorders. Read more

  • Pipeline

    Sensorion has two products in clinical trials, and with our efficient, in-house technology platform, we are well positioned to deliver and expand our pipeline. Read more

  • Investors

     Sensorion is focused on addressing treatment needs for 140 million of patients suffering from debilitating inner ear disorders having limited treatment options. Read more